Health

  • April 20, 2026

    No High Court Review In NY Nursing Home COVID Death Case

    The U.S. Supreme Court on Monday declined to review the dismissal of a civil suit against former New York Gov. Andrew Cuomo and other former state officials over COVID-19-related deaths in nursing homes that allegedly stemmed from the state's controversial early pandemic policies.

  • April 20, 2026

    SEC Says Adviser Traded On Firm Clients' Confidential Info

    The U.S. Securities and Exchange Commission sued an ex-investment advisory firm associate in Manhattan federal court on Monday, accusing him of using a close relative's brokerage account to trade ahead of market-moving announcements by three biopharmaceutical and biotechnology companies that his firm was researching.

  • April 20, 2026

    HR Director Says Telehealth Co. Fired Her After Miscarriage

    Iris Telehealth was hit with a lawsuit in Georgia federal court Monday from a former human resources manager who alleged she was not given the opportunity to take paid leave and was later fired after suffering a miscarriage last summer.

  • April 20, 2026

    PBMs Fail To Freeze Discovery In Mich.'s Drug-Pricing Case

    A pending motion to dismiss the Michigan attorney general's drug-pricing case against multiple pharmacy benefit managers does not preclude the PBMs from handing over agreements between PBMs and pharmacies to the state, a federal judge said in a motion hearing Monday.

  • April 20, 2026

    Doctors Fueled Man's Fatal Opioid Addiction, Philly Jury Told

    Counsel for the family of a man who died of an opioid overdose at age 26 told a Philadelphia jury that his doctors were responsible for pushing treatment plans that allowed him to develop an opioid addiction, leading to his untimely death, pointing to both physicians being paid speakers for the pharmaceutical companies whose medications they prescribed.

  • April 20, 2026

    Justices Won't Review Doctor's Captive Insurance Tax Fight

    The U.S. Supreme Court won't review the Internal Revenue Service's rejection of a Texas doctor's claim to $1 million in tax deductions linked to his urgent care network's captive insurance company, the court said Monday.

  • April 20, 2026

    Excess Insurer Says Healthcare Co. Can't Tap $25M Policy

    A private equity-backed hospital management company can't tap into its $25 million excess professional liability insurance for several underlying lawsuits until it forks over its $5 million self-insured retention payment, National Fire & Marine Insurance told a Tennessee federal court.

  • April 20, 2026

    Ex-Budget Official's Plea Hearing Fizzles In 2nd Bribery Case

    A change of plea hearing scheduled Monday afternoon in the second federal corruption trial of former Connecticut budget official Konstantinos M. Diamantis never materialized, with the parties emerging from chambers and leaving a Bridgeport courthouse without a judge entering the courtroom or going on the record. 

  • April 20, 2026

    Justices Mull Limits On Federal Review Of State Cases

    The U.S. Supreme Court on Monday wrestled with the potential impact of reining in — or even scrapping altogether — a 100-year-old doctrine that curbs litigants' ability to go to federal court to try to overturn a state court loss.

  • April 20, 2026

    Inspired Healthcare Creditors Object To Reid Collins Retention

    Inspired Healthcare's unsecured creditors have urged a Texas bankruptcy judge to deny the company's bid to retain Reid Collins & Tsai LLP to help investigate the debtor's pre-Chapter 11 conduct, saying that task should fall to unsecured creditors instead.

  • April 20, 2026

    'Unserious Leaders Are Unsafe': RFK Jr.'s Trans Edict Voided

    An Oregon federal judge struck down Health and Human Services Secretary Robert F. Kennedy Jr.'s efforts to enforce the agency's restrictions on gender-affirming care for minors, finding the restrictions unlawful and criticizing Kennedy's leadership and the policy declaration that introduced the changes. 

  • April 20, 2026

    GSK, Moderna Both Ordered To Provide More Info In Vax Fight

    A special master overseeing discovery disputes in GlaxoSmithKline's infringement suits over Moderna's COVID-19 and related respiratory syncytial virus vaccines ordered both companies to furnish information to each other, including financial data and licenses, according to an opinion unsealed Monday.

  • April 20, 2026

    Trump Orders Agencies To Fast-Track Psychedelic Therapies

    President Donald Trump on Saturday announced that his administration would instruct federal agencies to accelerate investigations into new therapies derived from psychedelic drugs and streamline patients' access to the treatments.

  • April 20, 2026

    Justices Won't Block Multimillion-Dollar Health Fraud Retrial

    A man accused of pocketing $12 million as a part of a larger $140 million scheme to defraud public and private healthcare programs can't get out of a second trial, as the U.S. Supreme Court declined to review his case on Monday.

  • April 20, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week delivered another mix of procedural rulings, fiduciary duty disputes and deal litigation, highlighting both the court's gatekeeping role and its continued focus on stockholder rights and transactional fairness.

  • April 20, 2026

    Kirkland, Goodwin Guide Lilly's Potential $7B Kelonia Buy

    Kirkland & Ellis LLP-advised pharmaceutical giant Eli Lilly & Co. on Monday announced plans to acquire clinical-stage biotechnology company Kelonia Therapeutics, led by Goodwin Procter LLP, in a deal worth up to $7 billion.

  • April 20, 2026

    3 Firms Advise Blue Owl's $2.4B Tampa Healthcare REIT Buy

    Blue Owl Capital agreed to pay $2.4 billion for healthcare-focused real estate investment trust Sila Realty Trust in a take-private deal announced Monday advised by Hogan Lovells, Kirkland & Ellis LLP and Dechert LLP.

  • April 20, 2026

    High Court Won't Hear 3rd Circ. J&J Class Cert. Appeal

    The U.S. Supreme Court on Monday said it won't review a class certification challenge in a securities class action over Johnson & Johnson's cancer-related talc products in the latest development in a closely watched dispute over how courts evaluate class certification in shareholder suits.

  • April 20, 2026

    Justices Won't Consider IP Theft Allegations Against Akin

    The U.S. Supreme Court on Monday rejected a former Cornell University graduate student's petition trying to revive his malpractice suit against Akin Gump Strauss Hauer & Feld LLP stemming from patent litigation against Illumina Inc. over DNA sequencing intellectual property.

  • April 17, 2026

    ITC Clears Apple's Redesigned Apple Watch For Import

    The U.S. International Trade Commission on Friday signed off on an administrative law judge's finding that Apple has sufficiently redesigned its smartwatch so it doesn't infringe Masimo Corp.'s patents and is therefore not bound by a 2023 import ban.

  • April 17, 2026

    9th Circ. Revives Doctor's PeaceHealth Whistleblower Suit

    A Ninth Circuit panel has reinstated a psychiatrist's claims that PeaceHealth Inc. retaliated against him for expressing concerns about potential Medicaid fraud at a Washington hospital, concluding on Friday that the district court overlooked evidence that the employer punished him by not renewing his employment contract.

  • April 17, 2026

    Missed Deadline Fatal To Patient's Stapler Suit, 4th Circ. Says

    The Fourth Circuit ruled Friday that a surgery patient's missed expert disclosure deadline rightfully ended his case seeking to hold Johnson & Johnson subsidiary Ethicon Endo-Surgery LLC liable for allegedly faulty staples used in his procedure.

  • April 17, 2026

    Federal Judge Blocks DOJ's DEI, Citizenship Grant Conditions

    A Rhode Island federal judge has temporarily blocked the U.S. Department of Justice from imposing new conditions related to diversity, equity and inclusion activities and immigration status on domestic violence assistance grants, finding a nonprofit coalition likely to succeed in a legal challenge.

  • April 17, 2026

    Plea Change Hearing Set For Former Conn. Budget Official

    A change of plea hearing has been scheduled for Monday afternoon for Konstantinos M. Diamantis, a former Connecticut budget official, elected politician and attorney facing an impending federal corruption trial for allegedly pocketing bribes while helping end a state Medicaid audit of an optometry practice operated by his friend's fiancée.

  • April 17, 2026

    Connecticut Cardiologist Files $4M Suit Over Alleged Ouster

    A Connecticut cardiologist alleges he suffered at least $4 million in damages due to his former practice's "repeated disrespect, bad faith" and reputational damage in the medical community for more than a decade, which culminated in his constructive discharge, filing a contract and defamation lawsuit in state court.

Expert Analysis

  • Series

    Law School's Missed Lessons: What Cross-Selling Truly Takes

    Author Photo

    Early-career attorneys may struggle to introduce clients to practitioners in other specialties, but cross-selling becomes easier once they know why it’s vital to their first years of practice, which mistakes to avoid and how to anticipate clients' needs, say attorneys at Moses & Singer.

  • How State FCA Activity May Affect Civil Fraud Enforcement

    Author Photo

    A growing trend of state attorneys general enforcing their False Claims Act analogues independently of the U.S. Department of Justice carries potential repercussions for civil fraud enforcement and qui tam litigation considerations, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwen Stamper at Vogel Slade.

  • Wage-Based H-1B Rule Amplifies Lottery Risks For Law Firms

    Author Photo

    Under the wage-based H-1B lottery rule taking effect Feb. 27, law firms planning to hire noncitizen law graduates awaiting bar admission should consider their options, as the work performed by such candidates may sit at the intersection of multiple occupational classifications with differing chances of success, says Jun Li at Reid & Wise.

  • Series

    Judges On AI: Practical Use Cases In Chambers

    Author Photo

    U.S. Magistrate Judge Allison Goddard in the Southern District of California discusses how she uses generative artificial intelligence tools in chambers to make work more efficient and effective — from editing jury instructions for clarity to summarizing key documents.

  • Assessing Compliance Risks Around TrumpRx Participation

    Author Photo

    As there are novel compliance obligations and potential political opposition related to the new TrumpRx online drug platform, companies intending to participate on the site should consider the pressure points that are likely to draw enforcement scrutiny, say attorneys at Sheppard.

  • California's New Privacy Laws Demand Preparation From Cos.

    Author Photo

    An increase in breach disclosures is coinciding with California's most comprehensive privacy and artificial intelligence legislation taking effect, illustrating the range of vulnerabilities organizations in the state face and highlighting that the key to successfully managing these requirements is investing in capabilities before they became urgent, says Camilo Artiga-Purcell at Kiteworks.

  • Series

    Trail Running Makes Me A Better Lawyer

    Author Photo

    Navigating the muddy, root-filled path of trail marathons and ultramarathons provides fertile training ground for my high-stakes fractional general counsel work, teaching me to slow down my mind when the terrain shifts, sharpen my focus and trust my training, says Eric Proos at Next Era Legal.

  • Predicting Actual Impact From CDC's New Vaccine Guidance

    Author Photo

    Recent federal changes to the childhood immunization schedule, reducing the number of vaccine recommendations from 18 to 11, do not automatically create enforceable obligations for parents, schools or healthcare providers, but may spur litigation and other downstream effects on school policies and state guidelines, says Mehdi Sinaki at Michelman & Robinson.

  • AI Scientific Discovery Order Implications For Life Sciences

    Author Photo

    President Donald Trump's November executive order establishing a government effort to use artificial intelligence to accelerate scientific discovery has the potential to leverage significant federal resources and data to support research, drug and device approvals, and AI model training in the life sciences sector, say attorneys at Hogan Lovells.

  • What Rescheduling Means For Cannabis Labels, Marketing

    Author Photo

    The proposed reclassification of cannabis is expected to bring heightened scrutiny of labeling, advertising and marketing from the U.S. Food and Drug Administration and the Federal Trade Commission, but the brands that tighten evidence, standardize operations and professionalize marketing controls now will see fewer surprises and better outcomes, say attorneys at Wilson Elser.

  • What's At Stake In Possible Circuit Split On Medicaid Rule

    Author Photo

    A recent Eleventh Circuit decision, reviving Florida's lawsuit against a federal rule that reduces Medicaid funding based on agreements between hospitals, sets up a potential circuit split with the Fifth Circuit, with important ramifications for states looking to private administrators to run provider tax programs, say Liz Goodman, Karuna Seshasai and Rebecca Pitt at FTI Consulting.

  • Malpractice Claim Assignability Continues To Divide Courts

    Author Photo

    Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.

  • Courts' Rare Quash Of DOJ Subpoenas Has Lessons For Cos.

    Author Photo

    In a rare move, three federal courts recently quashed or partially quashed expansive U.S. Department of Justice administrative subpoenas issued to providers of gender-affirming care, demonstrating that courts will scrutinize purpose, cabin statutory authority and acknowledge the profound privacy burdens of overbroad government demands for sensitive records, say attorneys at ArentFox Schiff.

  • Unpacking Dormant Commerce Clause Cannabis Circuit Split

    Author Photo

    Federal courts have reached differing conclusions as to whether state-legal cannabis is subject to the dormant commerce clause, with four opinions across three circuit courts in the last year demonstrating the continued salience of the dormant commerce clause debate to the nation's cannabis industry, regulators and policymakers, say attorneys at Perkins Coie.

  • Remote Patient Monitoring Is At Regulatory Inflection Point

    Author Photo

    With remote patient monitoring at the center of new federal pilot programs and a recent report from the U.S. Department of Health and Human Services' Office of Inspector General examining Medicare billing for those services, it is clear that balancing innovation and risk will be a central challenge ahead for digital health stakeholders, say attorneys at Morgan Lewis.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.